GSK3B and cardiac hypertrophy: NFATc4 is then released from the inhibitory effect of GSK3β, translocates into the nucleus and drives the expression of hypertrophic genes.131 In addition to mRNA modifications, noncoding RNA modifications have also been reported to regulate cardiac hypertrophy.